{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:45:52Z","timestamp":1760784352476,"version":"3.41.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00296-017-3821-3","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T04:49:39Z","timestamp":1507783779000},"page":"293-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review"],"prefix":"10.1007","volume":"38","author":[{"given":"Isabela Bruna Pires","family":"Borges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilda Guimar\u00e3es","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Giovane","family":"Misse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Katsuyuki","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"key":"3821_CR1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coph.2010.03.001","volume":"10","author":"MC Dalakas","year":"2010","unstructured":"Dalakas MC (2010) Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Opin Pharmacol 10:346\u2013352","journal-title":"Curr Opin Pharmacol"},{"key":"3821_CR2","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","volume":"372","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 372:1734\u20131747","journal-title":"N Engl J Med"},{"key":"3821_CR3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMc1506827","volume":"373","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 373:393\u2013394","journal-title":"N Engl J Med"},{"key":"3821_CR4","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325:1487\u20131498","journal-title":"N Engl J Med"},{"key":"3821_CR5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971\u2013982","journal-title":"Lancet"},{"key":"3821_CR6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"3821_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7326\/0003-4819-111-2-143","volume":"111","author":"PH Plotz","year":"1989","unstructured":"Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME (1989) Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 111:143\u2013157","journal-title":"Ann Intern Med"},{"key":"3821_CR8","first-page":"1523","volume-title":"Rheumatology","author":"K Nagaraju","year":"2003","unstructured":"Nagaraju K, Plotz PH, Miller FW (2003) Inflammatory muscle disease: etiology and pathogenesis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology. Elsevier, Toronto, pp 1523\u20131535"},{"key":"3821_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2011.11.005","volume":"222","author":"S Padala","year":"2012","unstructured":"Padala S, Thompson PD (2012) Statins as a possible cause of inflammatory and necrotizing myopathies. Atherosclerosis 222:15\u201321","journal-title":"Atherosclerosis"},{"key":"3821_CR10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","volume":"19","author":"E Bruckert","year":"2005","unstructured":"Bruckert E, Hayem G, Dejager S, Yau C, Biegaud B (2005) Mild to moderate muscular symptoms with high-dose statin therapy in hyperlipidemic patients: the PRIMO study. Cardiovasc Drugs Ther 19:403\u2013414","journal-title":"Cardiovasc Drugs Ther"},{"key":"3821_CR11","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1001\/archinte.165.22.2671","volume":"165","author":"KE Hansen","year":"2005","unstructured":"Hansen KE, Hildebrand JP, Ferguson EE, Stein JH (2005) Outcomes in 45 patients with statin-associated myopathy. Arch Intern Med 165:2671\u20132676","journal-title":"Arch Intern Med"},{"key":"3821_CR12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","volume":"17","author":"M Needham","year":"2007","unstructured":"Needham M, Fabian V, Knezevic W, Panegyres P, Zilko P, MastagliA FL (2007) Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord 17:194\u2013200","journal-title":"Neuromuscul Disord"},{"key":"3821_CR13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L et al (2011) Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 63:713\u2013721","journal-title":"Arthritis Rheum"},{"key":"3821_CR14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","volume":"15","author":"L Musset","year":"2016","unstructured":"Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C et al (2016) Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study. Autoimmun Rev 15:983\u2013993","journal-title":"Autoimmun Rev"},{"key":"3821_CR15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/BOR.0000000000000335","volume":"28","author":"I Pinal-Fernandez","year":"2016","unstructured":"Pinal-Fernandez I, Mammen AL (2016) Spectrum of immune-mediated necrotizing myopathies and their treatments. Curr Opin Rheumatol 28:619\u2013624","journal-title":"Curr Opin Rheumatol"},{"key":"3821_CR16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jacc.2016.04.037","volume":"68","author":"P Basharat","year":"2016","unstructured":"Basharat P, Lahouti AH, Paik JJ et al (2016) Statin-induced anti-HMGCR-associated myopathy. J Am Coll Cardiol 68:234\u2013235","journal-title":"J Am Coll Cardiol"},{"key":"3821_CR17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.23854","volume":"48","author":"P Mohassel","year":"2013","unstructured":"Mohassel P, Mammen AL (2013) Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. Muscle Nerve 48:477\u2013483","journal-title":"Muscle Nerve"},{"key":"3821_CR18","first-page":"649","volume":"327","author":"BB Schalke","year":"1992","unstructured":"Schalke BB, Schmidt B, Toyka K, Hartung HP (1992) Pravastatin-associated inflammatory myopathy. N Engl J Med 327:649\u2013650","journal-title":"N Engl J Med"},{"key":"3821_CR19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/rheumatology\/33.2.199","volume":"33","author":"FH Khattak","year":"1994","unstructured":"Khattak FH, Morris IM, Branford WA (1994) Simvastatin-associated dermatomyositis. Br J Rheumatol 33:199","journal-title":"Br J Rheumatol"},{"key":"3821_CR20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1445-5994.1995.tb02870.x","volume":"25","author":"C Hill","year":"1995","unstructured":"Hill C, Zeitz C, Kirkham B (1995) Dermatomyositis with lung involvement in a patient treated with simvastatin. Aust N Z J Med 25:745\u2013746","journal-title":"Aust N Z J Med"},{"key":"3821_CR21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/pgmj.72.853.694","volume":"72","author":"JL Rodriguez-Garcia","year":"1996","unstructured":"Rodriguez-Garcia JL, Serrano Commino M (1996) Lovastatin-associated dermatomyositis. Postgrad Med J 72:694","journal-title":"Postgrad Med J"},{"key":"3821_CR22","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(05)61628-5","volume":"349","author":"N Giodarno","year":"1997","unstructured":"Giodarno N, Senesi M, Mattiig Battisti E, Villanova M, Gennari C (1997) Polymyositis associated with simvastatin. Lancet 349:1600\u20131601","journal-title":"Lancet"},{"key":"3821_CR23","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9343(01)00711-2","volume":"110","author":"B No\u00ebl","year":"2001","unstructured":"No\u00ebl B, Cerottini JP, Panizzon RG (2001) Atorvastatin-induced dermatomyositis. Am J Med 110:670\u2013671","journal-title":"Am J Med"},{"key":"3821_CR24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.33588\/rn.3710.2003263","volume":"37","author":"G Riesco-Eizaguirre","year":"2003","unstructured":"Riesco-Eizaguirre G, Arpa-Guti\u00e9rrez FJ, Guti\u00e9rrez M, Toribio E (2003) Severe polymyositis with simvastatin use. Rev Neurol 37:934\u2013936","journal-title":"Rev Neurol"},{"key":"3821_CR25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/mus.20127","volume":"30","author":"OM Vasconcelos","year":"2004","unstructured":"Vasconcelos OM, Campbell WW (2004) Dermatomyositis-like syndrome and HMGCoA reductase inhibitor (statin) intake. Muscle Nerve 30:803\u2013807","journal-title":"Muscle Nerve"},{"key":"3821_CR26","first-page":"25","volume":"44","author":"A Takagi","year":"2004","unstructured":"Takagi A, Shiio Y (2004) Pravastatin-associated polymyositis, a case report. Rinsho Shinkeigaku 44:25\u201327","journal-title":"Rinsho Shinkeigaku"},{"key":"3821_CR27","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0151-9638(05)79565-X","volume":"132","author":"N Thual","year":"2005","unstructured":"Thual N, Penven K, Chevallier JM, Dompmartin A, Leroy D (2005) Fluvastatin-induced dermatomyositis. Ann Dermatol Venereol 132:996\u2013999","journal-title":"Ann Dermatol Venereol"},{"key":"3821_CR28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.revmed.2005.07.005","volume":"26","author":"P Zuech","year":"2005","unstructured":"Zuech P, Pauwels C, Duthoit C et al (2005) Pravastatin-induced dermatomyositis. Rev Med Interne 26:897\u2013902","journal-title":"Rev Med Interne"},{"key":"3821_CR29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.revmed.2003.10.013","volume":"25","author":"AL Fauchais","year":"2004","unstructured":"Fauchais AL, Iba BAJ, Maurage P et al (2004) Polymyositis induced or associated with lipid-lowering drugs: five cases. Rev Med Interne 25:294\u2013298","journal-title":"Rev Med Interne"},{"key":"3821_CR30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/ard.2007.075523","volume":"67","author":"L Sailler","year":"2008","unstructured":"Sailler L, Pereira C, Bagheri A et al (2008) Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study. Ann Rheum Dis 67:614\u2013619","journal-title":"Ann Rheum Dis"},{"key":"3821_CR31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00105-008-1637-5","volume":"60","author":"A Rasch","year":"2009","unstructured":"Rasch A, Schimmer M, Sander CA (2009) Simvastatin-induced dermatomyositis. Hautarzt 60:489\u2013493","journal-title":"Hautarzt"},{"key":"3821_CR32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2133.2009.09205.x","volume":"161","author":"O Inhoff","year":"2009","unstructured":"Inhoff O, Peitsch WK, Paredes BE, Goerdt S, Goebeler M (2009) Simvastatin-induced amyopathic dermatomyositis. Br J Dermatol 161:206\u2013208","journal-title":"Br J Dermatol"},{"key":"3821_CR33","doi-asserted-by":"crossref","unstructured":"Zaraa IR, Labb\u00e8ne I, Mrabet D, Zribi H, Chelly I, Zitouna M et al. (2011) Simvastatin-induced dermatomyositis in a 50-year-old man. BMJ Case Rep","DOI":"10.1136\/bcr.02.2011.3832"},{"key":"3821_CR34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3121\/cmr.2012.1110","volume":"11","author":"R Kanth","year":"2013","unstructured":"Kanth R, Shah MS, Flores RM (2013) Statin-associated polymyositis following omeprazole treatment. Clin Med Res 11:91\u201395","journal-title":"Clin Med Res"},{"key":"3821_CR35","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00296-017-3658-9","volume":"37","author":"M Oztas","year":"2017","unstructured":"Oztas M, Ugurlu S, Aydin O (2017) Atorvastatin-induced dermatomyositis. Rheumatol Int 37:1217\u20131219","journal-title":"Rheumatol Int"},{"key":"3821_CR36","doi-asserted-by":"publisher","unstructured":"Fania L, Didona D, Tonanzi T, Mazzanti C, Didona B (2017) Simvastatin-associated dermatomyositis. Dermatol Ther 30. doi: 10.1111\/dth.12480","DOI":"10.1111\/dth.12480"},{"key":"3821_CR37","unstructured":"Medical Research Council (1943) Aids to the investigation of peripheral nerve injuries. War memorandum n.\u00a07, 2\u00a0ed. Her Majesty\u2019s Stationery Office, London"},{"key":"3821_CR38","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2990.2012.01302.x","volume":"38","author":"W Stenzel","year":"2012","unstructured":"Stenzel W, Goebel HH, Aronica E (2012) Review: immune-mediated necrotising myopathies: a heterogeneous group of diseases with specific myopathological features. Neuropathol Appl Neurobiol 38:632\u2013646","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3821_CR39","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMra1515161","volume":"374","author":"AL Mammen","year":"2016","unstructured":"Mammen AL (2016) Statin-associated autoimmune myopathy. N Engl J Med 374:664\u2013669","journal-title":"N Engl J Med"},{"key":"3821_CR40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00124743-200202000-00011","volume":"8","author":"LF Flores-Su\u00e1rez","year":"2002","unstructured":"Flores-Su\u00e1rez LF, Morales H, Angeles A, Kraus A (2002) Drug-induced amyopathic dermatomyositis. J Clin Rheumatol 8:50\u201354","journal-title":"J Clin Rheumatol"},{"key":"3821_CR41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0248-8663(05)81354-2","volume":"12","author":"F Sauvaget","year":"1991","unstructured":"Sauvaget F, Piette JC, Herson S, De Gennes C, Duyckaerts C, Godeau P (1991) Fenofibrate induced polymyositis. Rev Med Interne 12:52\u201354","journal-title":"Rev Med Interne"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3821-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3821-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3821-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T09:59:41Z","timestamp":1750931981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3821-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["3821"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3821-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2017,10,12]]}}}